Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quest Pharmatech Inc
V.QPT
Alternate Symbol(s):
QPTFF
Healthcare
Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest...
Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:QPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 21, 2022 5:00pm
New Press Release - Quest PharmaTech Announces Results from AGM
TSX Venture: QPT EDMONTON, AB, July 21, 2022 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 19, 2022 annual general meeting of shareholders.The Company is pleased to announce the following 4 directors have been re-elected to the...
read article.
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jul 21, 2022 1:38pm
RE:Hmm...
Thanks ARIMA11, for the explanation. I did email Pierre Vermette. Have not heard back as yet. G1945V
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development
posted May 02, 2024 9:00am by
Saturn Oil & Gas Inc.
-
|
Saturn has followed up its success in previous years drilling in Southeast Saskatchewan to enhance its IP30 initial production rates and overall return on invested capital. Saturn has recently finished drilling one gross (1.0 net) Open Hole Multi-Lateral ("OHML") well in the Viewfield area of Southeast Saskatchewan with eight horizontal legs of up to two miles each ...read more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jul 21, 2022 1:30pm
Hmm...
https://ceo.ca/qpt?628915064c02 https://pulsenews.co.kr/view.php?sc=30800028&year=2022&no=360177 Canariabio is issuing convertible bonds worth 70 billion won to finance the deal
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jul 21, 2022 1:20pm
RE:RE:Interesting
Oregovomab (Flora5) was sold to OQP which spinned off OQPBio (CanariBio). As a result, QPT owns CAD$80M (convertible bonds) from OQPBio. Hence, there is an indirect ownership positions from QPT
...more
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jul 20, 2022 6:19am
RE:AGM
The landscape changed very much from the original April 22, 2020 agreement for the sale of OncoQuest assets to OncoQuest Pharmaceutical Inc, (OQP) (formerly Dual Industrial Co., Ltd.) and the
...more
(97)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jul 19, 2022 7:37am
AGM
It is happening today. G1945V
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jul 16, 2022 8:06am
RE:Interesting
ARIMA11, Interesting how? "We are excited about reaching this important milestone, which is a testament of the hard work that all our investigators, GOG leadership, team
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jul 15, 2022 11:25am
Interesting
https://ceo.ca/qpt?8db6d60bdba9
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Post by
bigstar10
on May 30, 2022 12:21pm
Bozo the clown
the clown ....Just lost $quick trying to run this up, lol
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on May 27, 2022 10:30am
RE:RE:RE:RE:RE:Zero news
"Company reported a net loss of $85,038,575 during the year ended January 31, 2022" This is a superficial loss due to the adjustments noted in Note 20 of the financials. ($57,754,078) &
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on May 27, 2022 9:42am
Interesting
https://clinicaltrials.gov/ct2/show/study/NCT04498117#contactlocation Updated today; There's a 154 Locations recruting now. They need 602 subjects: For Cohort 1 - Primary Surgery, 372
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on May 26, 2022 8:37pm
RE:RE:RE:RE:Zero news
Financial are out and its definitely not pretty! Basic income (loss) / share at Jan 31 22 (-0.50) vs. Jan 31 2021 (+1.13) is interesting and notable. Auditor Statements Emphasis of Matter
...more
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on May 26, 2022 9:03am
RE:RE:RE:Zero news
What other choice do we have? G1945V
(3)
•••
PosNeg1
X
View Profile
View Bullboard History
Comment by
PosNeg1
on May 25, 2022 10:37am
RE:RE:Zero news
A phase III cancer immunotherapy program in clinical trials currently and a SP that has been 0.10 or so for several years. Hello? Fate in CEO's hands, I hope not.
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on May 22, 2022 10:23am
RE:Zero news
If Quest Pharmatech Inc's ("QPT") survival depends on them borrowing a million dollars to stay alive, from OncoQuest Inc, rather than generating income on their own this does not bode
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon